Status not kept up to date
A Clinical Trial Evaluating the Pan-vascular Interventional Robotic System for Panvascularization Interventional Surgery
NCT06502938 · Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. · Updated 16 July 2024
- What is being tested
- Pan-vascular interventional robotic system; Traditional artificial percutaneous coronary intervention
- For
- Percutaneous Coronary Intervention
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 85 years. About 159 people. The full rules are on the registry page.
- Where
- China (5 sites)
- When
- Starts or started 15 July 2024, ends 15 Dec 2025. Registered 16 July 2024.
- Results
- None posted yet.
In the researchers' words
The purpose of this prospective, randomized, open, parallel controlled, multicenter trial is to investigate the efficacy and safety of the pan-vascular interventional robotic system for percutaneous coronary intervention (PCI). Investigators will evaluate clinical success, technical success, and record intraoperative data (PCI time, total operating time, contrast agent dose, radiation exposure dose, etc.). All subjects were followed up on the day of surgery, before discharge and 1 month after surgery to observe the safety indicators.
Sites
- Beijing Anzhen Hospital,Capital Medical UniversityBeijing, Beijing Municipality, China
- The First Affiliated Hospital,Sun Yat-sen UniversityGuanzhou, Guandong, China
- Linfen Central HospitalShanxi, Linfen, China
- Shanghai Zhongshan HospitalShanghai, Shanghai Municipality, China
- The Affiliated Hospital of Hangzhou Normal UniversityHangzhou, Zhejiang, China